{"chebi_id":"57812","chebi_name":"CMP-N-acetyl-\u03b2-neuraminate(2\u2212)","chebi_synonyms":["CMP-N-acetyl-\u03b2-neuraminate dianion","cytidine 5'-(5-acetamido-3,5-dideoxy-D-glycero-\u03b2-D-galacto-non-2-ulopyranosylonate monophosphate)","CMP-N-acetyl-\u03b2-neuraminate"],"diffprof_id_observed":["MTBLS379_0002_00000001"],"diffprof_id_var_observed":[],"inchikey":"TXCIAUNLDRJGJZ-BILDWYJOSA-L","inn_name":"","iupac_name":"cytidine 5'-(5-acetamido-3,5-dideoxy-<small>D</small>-<i>glycero</i>-\u03b2-<small>D</small>-<i>galacto</i>-non-2-ulopyranosylonate monophosphate)","num_study_observed":1,"reactome_ids":["R-HSA-1430728","R-HSA-157118","R-HSA-162582","R-HSA-1630316","R-HSA-1638074","R-HSA-1643685","R-HSA-1660662","R-HSA-1912420","R-HSA-1912422","R-HSA-2022854","R-HSA-3560782","R-HSA-3656243","R-HSA-3781865","R-HSA-382551","R-HSA-392499","R-HSA-4085001","R-HSA-425397","R-HSA-425407","R-HSA-428157","R-HSA-446193","R-HSA-446203","R-HSA-446219","R-HSA-5173105","R-HSA-556833","R-HSA-5619037","R-HSA-5619102","R-HSA-5619115","R-HSA-5663020","R-HSA-5663205","R-HSA-5668914","R-HSA-597592","R-HSA-71387","R-HSA-727802","R-HSA-9033658","R-HSA-9037629","R-HSA-913709","R-HSA-9678108","R-HSA-9679506","R-HSA-9683673","R-HSA-9683701","R-HSA-9694516","R-HSA-9694635","R-HSA-9694719","R-HSA-977068","R-HSA-9772573","R-HSA-9824446","R-HSA-9840309"],"reactome_names":["Metabolism","Signaling by NOTCH","Signal Transduction","Glycosaminoglycan metabolism","Keratan sulfate/keratin metabolism","Disease","Glycosphingolipid metabolism","Pre-NOTCH Processing in Golgi","Pre-NOTCH Expression and Processing","Keratan sulfate biosynthesis","Diseases associated with glycosaminoglycan metabolism","Defective ST3GAL3 causes MCT12 and EIEE15","Diseases of glycosylation","Transport of small molecules","Metabolism of proteins","Sialic acid metabolism","Transport of vitamins, nucleosides, and related molecules","SLC-mediated transmembrane transport","Sphingolipid metabolism","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein","Asparagine N-linked glycosylation","Synthesis of substrates in N-glycan biosythesis","O-linked glycosylation","Metabolism of lipids","Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)","SLC transporter disorders","Disorders of transmembrane transporters","Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)","Infectious disease","Diseases of metabolism","Post-translational protein modification","Metabolism of carbohydrates and carbohydrate derivatives","Transport of nucleotide sugars","Blood group systems biosynthesis","Lewis blood group biosynthesis","O-linked glycosylation of mucins","SARS-CoV-1 Infection","SARS-CoV Infections","Maturation of protein 3a","Translation of Structural Proteins","SARS-CoV-2 Infection","Translation of Structural Proteins","Maturation of protein 3a","Termination of O-glycan biosynthesis","Late SARS-CoV-2 Infection Events","Viral Infection Pathways","Glycosphingolipid biosynthesis"],"study_id_observed":["MTBLS379"],"study_id_var_observed":[],"synonym_name":"CMP-<em>N</em>-acetyl-\u03b2-neuraminate dianion"}